Growth Metrics

OmniAb (OABI) Cash & Current Investments (2021 - 2026)

OmniAb (OABI) reported Cash & Current Investments of $43.0 million for Q1 2026, down 1.44% year-over-year from $43.6 million in Q1 2025, and down 11.56% on a QoQ basis from $48.6 million in Q4 2025.

OmniAb (OABI) has 6 years of Cash & Current Investments data on file, last reported at $43.0 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 1.44% year-over-year to $43.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.0 million (down 1.44% YoY) and the FY2025 annual result came in at $48.6 million, down 1.76% from the prior year.
  • Cash & Current Investments retreated to $43.0 million in Q1 2026 per OABI's latest filing, from $48.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $113.6 million in Q1 2023 and bottomed at $19847.0 in Q3 2022.
  • The 5-year median for Cash & Current Investments is $57.2 million (2024), against an average of $56.5 million.
  • The widest annual swing landed in 2022, when Cash & Current Investments slumped 94.52%; it then soared 486764.51% in 2023.
  • Tracing OABI's Cash & Current Investments over 5 years: stood at $88.3 million in 2022, then retreated by 1.45% to $87.0 million in 2023, then sank by 43.15% to $49.5 million in 2024, then dropped by 1.76% to $48.6 million in 2025, then dropped by 11.56% to $43.0 million in 2026.
  • Per Business Quant, the three latest OABI Cash & Current Investments figures stand at $43.0 million (Q1 2026), $48.6 million (Q4 2025), and $59.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.13 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.25 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.75 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.01 Bn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 42.97 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 42.97 Mn
Dec 31, 2025 48.58 Mn
Sep 30, 2025 59.50 Mn
Jun 30, 2025 41.62 Mn
Mar 31, 2025 43.60 Mn
Dec 31, 2024 49.45 Mn
Sep 30, 2024 59.38 Mn
Jun 30, 2024 57.23 Mn
Mar 31, 2024 69.01 Mn
Dec 31, 2023 86.98 Mn
Sep 30, 2023 96.63 Mn
Jun 30, 2023 103.15 Mn
Mar 31, 2023 113.61 Mn
Dec 31, 2022 88.27 Mn
Sep 30, 2022 19,847.00
Jun 30, 2022 159,194.00
Mar 31, 2022 434,629.00
Sep 30, 2021 362,203.00
Jun 30, 2021 36,145.00